Literature DB >> 30277839

Loss of lipid phosphatase SHIP1 promotes macrophage differentiation through suppression of dendritic cell differentiation.

Eui Young So1, Changqi Sun2, Anthony M Reginato2, Patrycia M Dubielecka1, Toru Ouchi3, Olin D Liang1.   

Abstract

SH2-containing inositol 5'-phosphatase-1 (SHIP1) deficiency in mice results in abnormal myeloid expansion, and proinflammatory conditions in the lung. However, the mechanisms involved in SHIP1-mediated regulation of myeloid differentiation remain unclear. Here we show that SHIP1 is a key regulator of early differentiation for dendritic cells (DCs). We also provide critical evidence to modify the function of SHIP1 in in vitro development of BMDCs using the recent framework of defining DCs. We found that loss of SHIP1 suppresses GM-CSF-induced formation of bone marrow-derived DC (BMDC) colonies, leading to reduced BMDC number in BM cell culture. The number of maturated BMDCs decreased in SHIP1-KO culture, due to reduction of immature BMDCs, suggesting SHIP1 is critical for lineage commitment rather than for maturation from myeloid precursors to DCs. We further showed that F4/80+/MHCIIlow BM macrophage-like cells (BMMs) were the main population of SHIP1-KO BM culture. Treatment of wild-type BM culture with 3 α-aminocholestane (3AC), a specific inhibitor for functional activity of SHIP1, caused a similar developmental defect in BMDCs as seen in SHIP1-KO cells, resulting in the absence of BMDC colony, and increased number of BMMs in BM culture. In conclusion, our results suggest that differentiation of BMDCs are markedly impaired under SHIP1 deficient condition, which causes skewed development of myeloid lineage cells manifested as pathological conditions associated with an excess of macrophage population.

Entities:  

Keywords:  SHIP1; bone marrow; dendritic cells; differentiation; macrophage; maturation; myeloid precursor

Year:  2018        PMID: 30277839      PMCID: PMC6343724          DOI: 10.1080/15384047.2018.1523846

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  33 in total

1.  SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival.

Authors:  Q Liu; T Sasaki; I Kozieradzki; A Wakeham; A Itie; D J Dumont; J M Penninger
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

2.  Myeloid cell-specific expression of Ship1 regulates IL-12 production and immunity to helminth infection.

Authors:  S Hadidi; F Antignano; M R Hughes; S K H Wang; K Snyder; G M Sammis; W G Kerr; K M McNagny; C Zaph
Journal:  Mucosal Immunol       Date:  2012-04-25       Impact factor: 7.313

3.  Dendritic-cell expression of Ship1 regulates Th2 immunity to helminth infection in mice.

Authors:  Matthew J Gold; Frann Antignano; Michael R Hughes; Colby Zaph; Kelly M McNagny
Journal:  Eur J Immunol       Date:  2015-11-30       Impact factor: 5.532

4.  Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.

Authors:  Gwenny M Fuhler; Robert Brooks; Bonnie Toms; Sonia Iyer; Elizabeth A Gengo; Mi-Young Park; Matthew Gumbleton; Dennis R Viernes; John D Chisholm; William G Kerr
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

5.  Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-1.

Authors:  Ivan Ivetac; Rajendra Gurung; Sandra Hakim; Kristy A Horan; David A Sheffield; Lauren C Binge; Philip W Majerus; Tony Tiganis; Christina A Mitchell
Journal:  EMBO Rep       Date:  2009-03-27       Impact factor: 8.807

6.  SHIP-1 deficiency in the myeloid compartment is insufficient to induce myeloid expansion or chronic inflammation.

Authors:  M J Maxwell; N Srivastava; M-Y Park; E Tsantikos; R W Engelman; W G Kerr; M L Hibbs
Journal:  Genes Immun       Date:  2014-03-06       Impact factor: 2.676

7.  Dual enhancement of T and NK cell function by pulsatile inhibition of SHIP1 improves antitumor immunity and survival.

Authors:  Matthew Gumbleton; Raki Sudan; Sandra Fernandes; Robert W Engelman; Christopher M Russo; John D Chisholm; William G Kerr
Journal:  Sci Signal       Date:  2017-10-10       Impact factor: 8.192

8.  Unique proteomic signatures distinguish macrophages and dendritic cells.

Authors:  Lev Becker; Ning-Chun Liu; Michelle M Averill; Wei Yuan; Nathalie Pamir; Yufeng Peng; Angela D Irwin; Xiaoyun Fu; Karin E Bornfeldt; Jay W Heinecke
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

9.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

10.  Translational initiation regulated by ATM in dendritic cells development.

Authors:  E Y So; T Ouchi
Journal:  Cell Death Dis       Date:  2014-09-11       Impact factor: 8.469

View more
  2 in total

Review 1.  Extracellular Vesicle/Macrophage Axis: Potential Targets for Inflammatory Disease Intervention.

Authors:  Desheng Tang; Feng Cao; Changsheng Yan; Kun Fang; Jiamin Ma; Lei Gao; Bei Sun; Gang Wang
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

2.  Inhibition of lipid phosphatase SHIP1 expands myeloid-derived suppressor cells and attenuates rheumatoid arthritis in mice.

Authors:  Eui-Young So; Changqi Sun; Keith Q Wu; Patrycja M Dubielecka; Anthony M Reginato; Olin D Liang
Journal:  Am J Physiol Cell Physiol       Date:  2021-07-21       Impact factor: 5.282

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.